Company profile
KIYAN PHARMA株式会社· Corporate Number: 7010401124902
This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.
RegBase Evidence Report
Company identity, confirmed enforcement records, Official Gazette notices, and source-review fields for internal due-diligence files.
| Display name | KIYAN PHARMA株式会社 | Original name | KIYAN PHARMA株式会社 |
|---|---|---|---|
| Corporate Number | 7010401124902 | Status | Active |
| Confirmed enforcement | 0 record(s) | Official Gazette | 1 notice(s) |
| Registry changes | 0 item(s) | Related companies | 0 candidate(s) |
| Latest public record | 19 Aug 2024 | ||
This report summarizes public-source records collected by RegBase. It is not a credit opinion, sanctions result, legal conclusion, or procurement approval. Verify material findings against the linked original Japanese source before relying on them.
| English display | KIYAN PHARMA株式会社 (Japanese original) |
|---|---|
| Japanese name | KIYAN PHARMA株式会社 |
| Address | 静岡県袋井市久能３０５６番地 |
| Representative | Not recorded |
| Industry | Not recorded |
| Official website | Not recorded |
| Target URL | https://regbase.jp/en/company/990a8256-c1c8-4439-93ad-35f9888dd6c7 |
|---|---|
| Regulatory enforcement disclosures | No confirmed linked record in RegBase monitored coverage |
| Official Gazette notices | 1 notice(s) linked in RegBase coverage |
| Registry-source timestamps | Corporate Number site: 16 Jul 2026 / gBizINFO: 16 Jul 2026 / EDINET: not recorded |
No confirmed enforcement record is currently linked to this company in RegBase monitored sources.
| Citation | 19 Aug 2024 Main Edition 第1287号 p.31 |
|---|---|
| Published name | KIYAN PHARMA株式会社 |
| Address / court | 静岡県袋井市久能三〇五六番地 |
| Excerpt | This is a financial statement notice announcing the reduction of capital and capital reserve by 100 million yen each, with a one-month objection period for creditors. |
| Original sources checked | |
|---|---|
| Reviewer / date | |
| Internal notes |
Current page: Company profile
This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.
Free report
Includes company identity, enforcement history, Official Gazette notices, source-review fields, and reviewer notes for internal due-diligence files.
Related tool Kiroku
Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.
You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.
Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.
Official Gazette
KIYAN PHARMA Capital and Reserve Reduction Notice
Capital and reserve reduction noticeCapital or reserve notice第 １２８７ 号 令和６年８月１９日月曜日 官 報 （本 紙） 公 告 会社その他の公告資本金及び準備金の額の減少公告 page="0031" 当社は、資本金の額を一億円、資本準備金の額を一億円減少し、それぞれ一億円、一億円とすることにいたしました。 この決定に対し異議のある債権者は、本公告掲載の翌日から一箇月以内にお申し出下さい。 なお、最終貸借対照表の開示状況は次のとおりです。 https://www.kiyan.jp/ 令和六年八月十九日静岡県袋井市久能三〇五六番地ＫＩＹＡＮ ＰＨＡＲＭＡ株式会社 代表取締役 畑 宏芳 ©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.
No enforcement records are currently listed in RegBase's monitored sources.
RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.
About this English name
No official English name source is recorded. The original Japanese name is shown.
If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.
This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.